Your browser doesn't support javascript.
loading
Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to Go.
Smith, Maxwell L; Hariri, Lida P; Mino-Kenudson, Mari; Dacic, Sanja; Attanoos, Richard; Borczuk, Alain; Colby, Thomas V; Cooper, Wendy; Jones, Kirk D; Leslie, Kevin O; Mahar, Annabelle; Larsen, Brandon T; Cavazza, Alberto; Fukuoka, Jun; Roden, Anja C; Sholl, Lynette M; Tazelaar, Henry D; Churg, Andrew; Beasley, Mary Beth.
Afiliación
  • Smith ML; From the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Smith, Colby, Leslie, Larsen, Tazelaar).
  • Hariri LP; the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston (Hariri, Mino-Kenudson).
  • Mino-Kenudson M; the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston (Hariri, Mino-Kenudson).
  • Dacic S; the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dacic).
  • Attanoos R; School of Medicine, Cardiff University, Cardiff, United Kingdom (Attanoos).
  • Borczuk A; the Department of Pathology, Weill Cornell Medicine, New York, New York (Borczuk).
  • Colby TV; From the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Smith, Colby, Leslie, Larsen, Tazelaar).
  • Cooper W; Tissue Pathology and Diagnostic Oncology, NSW Pathology, Royal Prince Alfred Hospital, Sydney, NSW, Australia (Cooper).
  • Jones KD; Sydney Medical School, University of Sydney, Sydney, NSW, Australia (Cooper).
  • Leslie KO; the Department of Pathology, University of California San Francisco, San Francisco (Jones).
  • Mahar A; From the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Smith, Colby, Leslie, Larsen, Tazelaar).
  • Larsen BT; Royal Prince Alfred Hospital, Camperdown, NSW, Australia (Mahar).
  • Cavazza A; From the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Smith, Colby, Leslie, Larsen, Tazelaar).
  • Fukuoka J; Pathology Unit, AUSL/IRCCS di Reggio Emilia, Reggio Emilia, Italy (Cavazza).
  • Roden AC; the Department of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan (Fukuoka).
  • Sholl LM; the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota (Roden).
  • Tazelaar HD; the Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Sholl).
  • Churg A; From the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Smith, Colby, Leslie, Larsen, Tazelaar).
  • Beasley MB; the Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada (Churg).
Arch Pathol Lab Med ; 144(12): 1477-1489, 2020 12 01.
Article en En | MEDLINE | ID: mdl-32614648
ABSTRACT
CONTEXT.­ Accurate diagnosis of idiopathic pulmonary fibrosis (IPF) requires multidisciplinary diagnosis that includes clinical, radiologic, and often pathologic assessment. In 2018, the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and the Latin American Thoracic Society (ATS/ERS/JRS/ALAT) and the Fleischner Society each published guidelines for the diagnosis of IPF, which include criteria for 4 categories of confidence of a histologic usual interstitial pneumonia (UIP) pattern. OBJECTIVE.­ To (1) identify the role of the guidelines in pathologic assessment of UIP; (2) analyze the 4 guideline categories, including potential areas of difficulty; and (3) determine steps the Pulmonary Pathology Society and the greater pulmonary pathology community can take to improve current guideline criteria and histopathologic diagnosis of interstitial lung disease. DATA SOURCES.­ Data were derived from the guidelines, published literature, and clinical experience. CONCLUSIONS.­ Both guidelines provide pathologists with a tool to relay to the clinician the likelihood that a biopsy represents UIP, and serve as an adjunct, not a replacement, for traditional histologic diagnosis. There are multiple challenges with implementing the guidelines, including (1) lack of clarity on the quantity and quality of histologic findings required, (2) lack of recognition that histologic features cannot be assessed independently, and (3) lack of guidance on how pathologists should incorporate clinical and radiographic information. Current criteria for "probable UIP" and "indeterminate for UIP" hinder accurate reflection of the likelihood of IPF. These challenges highlight the need for further morphologic-based investigations in the field of pulmonary pathology.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Enfermedades Pulmonares Intersticiales / Fibrosis Pulmonar Idiopática Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Arch Pathol Lab Med Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Guías de Práctica Clínica como Asunto / Enfermedades Pulmonares Intersticiales / Fibrosis Pulmonar Idiopática Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Arch Pathol Lab Med Año: 2020 Tipo del documento: Article